Search Results
Results found for "Montana Molecular"
- Mapping Motion: Intermediate States, Deorphanization & Discovery
Triple Labeling Resolves a GPCR Intermediate State by Using Three-Color Single Molecule FRET .
- InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...
Collaborative efforts aim to accelerate and improve the prediction of first-in-class small molecule agonists
- 📰 GPCR Weekly News, April 15 to 21, 2024
GPCR Symposia Join us on June 7th for our symposium on Structural and Molecular Insights into GPCR Function
- G protein-coupled receptor signaling: transducers and effectors
continued study of their function and mechanism of action, there is a greater understanding of how effector molecules
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
Pharmacological chaperones are cell-permeant small molecules that engage nascent mutant GPCRs in the mutant follicle-stimulating hormone receptors (FSHRs) with poor cell surface expression using a small-molecule
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
GPCR dimers are very attractive molecular entities since they have been found to drive biased signalling
- 📰 GPCR Weekly News, May 13 to 19, 2024
Adhesion GPCR with Multiple Roles in Human Diseases, Current Status and Future Perspective Structural and Molecular
- Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans
Therefore, the ascaroside signaling system provides a unique example of a signaling molecule that regulates C. elegans secretes a family of small-molecule pheromones called ascarosides, which serve various functions
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
This 28-day trial will test the pharmacokinetics and safety profile of Inversago’s lead molecule, INV
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
former colleagues and their description of the company was very intriguing: a biology focused, small molecule
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
class A GPCR-Gi complex structures is observed in CX3CR1, which may correlate with three cholesterol molecules
- GPR108 is required for gambogic acid inhibiting NF-κB signaling in cancer
Overall, our findings supported GPR108 as a promising therapeutic target of cancer, and provided a small molecule
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules
- Allosteric modulation of GPCRs: From structural insights to in silico drug discovery
, we provide a systematic analysis of the currently available GPCR structures in complex with small-molecule
- The regulation of PKA signaling in obesity and in the maintenance of metabolic health
PKA facilitates the actions of hormones, neurotransmitters and other signaling molecules that bind G-protein
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
structure-based technology has passed a key test, in enabling the discovery of orally available small molecules
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
Keep pushing the boundaries, because your work moves molecules and medicine forward.
- Drug Discovery Picks Up the Pace, Stays on Target
They include small molecules that conditionally modulate proteins in their functional state; three-dimensional
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
studied by protein mapping using the FTMap server, which determines the clustering of small organic probe molecules
- Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
approximately 850 GPCRs) has been successfully drugged, and obtaining highly potent and selective small molecules
- GPCR kinase phosphorylation of distal C-tail sites specifies βarrestin1-mediated signaling by...
phosphorylation sites are required for recruitment of the adaptor protein STAM1 (signal-transducing adaptor molecule
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
The development of new CB2-related pharmacological and genetic tools, including the first small molecule
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
parameters of serotonin1A receptors in normal cells are consistent with models describing the diffusion of molecules
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
This talk gave a general idea of what goes into designing small molecule drugs, using state-of-the-art
- Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...
Pharmacological targeting of cGAS/STING-YAP signaling by both a small-molecule STING agonist, SR-717,
- Engineered synaptic tools reveal localized cAMP signaling in synapse assembly
Here, we describe new tools, referred to as "SynTAMs" for synaptic targeting molecules, that enable localized
- Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and ...
essential in biology and understanding how cells integrate signals from a variety of information-coding molecules
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
this accuracy to synthetic compounds, limiting its utility in drug discovery involving novel drug-like molecules
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
Ambiguous Decision Gates: Molecules advance or stall based on vibes, not criteria.